WallStreetZenWallStreetZen

NASDAQ: RPTX
Repare Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RPTX

Based on 3 analysts offering 12 month price targets for Repare Therapeutics Inc.
Min Forecast
$14.00+16.47%
Avg Forecast
$18.67+55.3%
Max Forecast
$26.00+116.31%

Should I buy or sell RPTX stock?

Based on 3 analysts offering ratings for Repare Therapeutics Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RPTX stock forecasts and price targets.

RPTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Stifel Nicolaus
Bottom 7%
7
Strong BuyUpgrades$16.00+33.11%2023-06-09
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$26.00+116.31%2023-06-09
Morgan Stanley
Top 27%
74
HoldMaintains$14.00+16.47%2023-02-27

1 of 1

Forecast return on equity

Is RPTX forecast to generate an efficient return?
Company
N/A
Industry
0.06%
Market
72.15%

Forecast return on assets

Is RPTX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.09%

RPTX revenue growth forecast

How is RPTX forecast to perform vs Biotechnology companies and vs the US market?
Company
-39.8%
Industry
40.17%
Market
8.37%
RPTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RPTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RPTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RPTX$12.02$18.67+55.30%Buy
ITOS$14.24$39.67+178.56%Strong Buy
AMRN$1.26$3.00+138.10%Strong Buy
AUTL$2.87$8.25+187.46%Strong Buy
TRDA$14.95$25.00+67.22%Buy
View Top Biotech Stocks

Repare Therapeutics Stock Forecast FAQ

Is Repare Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: RPTX) stock is to Buy RPTX stock.

Out of 3 analysts, 1 (33.33%) are recommending RPTX as a Strong Buy, 1 (33.33%) are recommending RPTX as a Buy, 1 (33.33%) are recommending RPTX as a Hold, 0 (0%) are recommending RPTX as a Sell, and 0 (0%) are recommending RPTX as a Strong Sell.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.

What is RPTX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: RPTX) forecast ROE is N/A, which is considered weak.

What is RPTX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year RPTX price target, the average RPTX price target is $18.67, with the highest RPTX stock price forecast at $26.00 and the lowest RPTX stock price forecast at $14.00.

On average, Wall Street analysts predict that Repare Therapeutics's share price could reach $18.67 by Jun 9, 2024. The average Repare Therapeutics stock price prediction forecasts a potential upside of 55.3% from the current RPTX share price of $12.02.

What is RPTX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: RPTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.09%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.